13F filing recap · Q3 2014

What did Matrix Asset Advisors buy in Q3 2014?

Reported stock-position changes between this filing and the previous one.

Stock value

$859.75M

Positions

Estimated turnover

3.9%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

SDYSPDR Series Trust$233.0Kreported value+3.1K shares SVONSevion Therapeutics, Inc.$34.0Kreported value+21.1K shares

Increased positions

ETNEaton Corporation Plc$25.85Mreported value+59.6K shares+17.1%BBTTruist Financial Corp$25.83Mreported value+8.5K shares+1.2%OXYOccidental Petroleum Corporation$25.62Mreported value+639 shares+0.2%DDE.I. du Pont de Nemours and Company$25.27Mreported value+11.7K shares

Reduced positions

JPMJPMorgan Chase & Co$35.21Mreported value-13.8K shares-2.3%WFCWells Fargo & Company/mn$33.58Mreported value-10.5K shares-1.6%MSFTMicrosoft Corporation$28.56Mreported value-53.4K shares-8.0%JNJJohnson & Johnson$28.36Mreported value-13.1K shares

Exited positions

23129V109CurrencyShares Swiss Franc Tru$220.0Kprior reported value-2.0K shares-100.0%ELOXEloxx Pharmaceuticals, Inc.$56.0Kprior reported value-20.0K shares-100.0%